查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606754

藥物發現資訊學市場：按解決方案、功能、最終用戶、應用分類 - 2025-2030 年全球預測

Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年藥物發現資訊學市場規模為29億美元，預計2024年將達到31.9億美元，複合年成長率為9.92%，到2030年將達到56.4億美元。

藥物發現資訊學涉及應用計算、統計和資訊技術來改進藥物發現過程。這種需求源於靶向生物活性化合物的巨大複雜性，以及對成本效率和加速藥物發現過程的日益成長的需求。其應用範圍包括藥物標靶辨識、先導化合物搜尋、測定開發和虛擬篩檢。最終用途包括製藥公司、生物技術公司、受託研究機構和學術機構。

主要市場統計
基準年[2023] 29億美元
預測年份 [2024] 31.9億美元
預測年份 [2030] 56.4億美元
複合年成長率（%） 9.92%

市場成長受到巨量資料分析、人工智慧和機器學習進步的顯著影響，這些進步提高了藥物發現過程中的預測準確性。個人化醫療的普及和雲端基礎的解決方案的日益採用進一步推動了這一成長。機會包括整合人工智慧和資訊學以實現精準醫療、共用分子資料的合作計劃以及擴展到新興市場。儘管存在這些機遇，但挑戰包括資訊學工具的高成本和資料管理的複雜性。嚴格的監管和資料隱私問題也為市場擴張帶來了障礙。

可以在開發直覺的資料視覺化使用者介面、簡化跨平台資料整合以及提高演算法的穩健性以實現更好的預測模型等領域促進創新。公司應該專注於建立可擴展的解決方案，以不斷適應藥物發現過程中產生的不斷成長的資料量。我們也與學術機構和行業相關人員合作，共用知識和資源並促進創新。

該市場充滿活力且競爭激烈，許多參與者為其快速發展做出了貢獻。公司應優先考慮保持技術趨勢的前沿，促進跨學科研究，並透過特定治療領域的資訊學解決方案獲得競爭優勢。策略投資和創新合作的結合使公司能夠有效應對藥物發現資訊學的複雜性並推動市場擴張和成功。

市場動態：揭示快速發展的藥物發現資訊學市場的關鍵市場洞察

供需的動態交互作用正在改變藥物發現資訊學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 罕見疾病和孤兒病管理對精準醫療的需求不斷增加
    • 政府對藥物發現程序的有利支持
    • 生物資訊軟體在藥物發現和藥物開發的使用增加
  • 市場限制因素
    • 開發生物資訊學基礎設施的龐大成本
  • 市場機會
    • 藥物發現資訊學開發的潛在研究投資
    • 將下一代技術整合到藥物發現程序中
  • 市場挑戰
    • 缺乏技術精湛、經驗豐富的專業人員

波特五力：駕馭藥物發現資訊學市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解藥物發現資訊學市場的外部影響

外部宏觀環境因素在塑造藥物發現資訊學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥物發現資訊學市場的競爭狀況

對藥物發現資訊學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣藥物發現資訊學市場供應商的績效評估

FPNV定位矩陣是評估藥物發現資訊學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製藥物發現資訊學市場的成功之路

藥物發現資訊學市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 罕見疾病和不治之症管理中對精準醫學的需求不斷增加
      • 政府對藥物發現程序的有利支持
      • 在藥物發現和開發中增加生物資訊軟體的使用
    • 抑制因素
      • 開發生物資訊學基礎設施需要大量資金
    • 機會
      • 藥物發現資訊學發展的潛在研究投資
      • 將下一代技術整合到藥物發現過程中
    • 任務
      • 缺乏技術精湛、經驗豐富的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章藥物發現資訊學市場：按解決方案

  • 服務
  • 軟體

第7章按功能分類的藥物發現資訊學市場

  • 對接
  • 準備庫和資料庫
  • 分子建模
  • 定序和目標資料分析

第 8 章藥物發現資訊學市場：依最終使用者分類

  • 合約研究組織（CRO）
  • 製藥和生物技術公司

第9章藥物發現資訊學市場：按應用

  • 藥物開發
    • 臨床試驗
    • 臨床前測試
  • 藥物發現

第10章美洲藥物發現資訊學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥物發現資訊學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的藥物發現資訊學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Accenture PLC
  • Agilent Technologies, Inc.
  • Aragen Life Sciences Ltd.
  • Boehringer Ingelheim International GmbH
  • Cadence Design Systems, Inc.
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • ChemAxon Ltd.
  • Cognizant Technology Solutions Corporation
  • Collaborative Drug Discovery, Inc
  • Crown Bioscience, Inc.
  • Dassault Systemes SE
  • Eurofins DiscoverX Products LLC
  • Evotec AG
  • Illumina, Inc.
  • Infosys Limited
  • InSilico Medicine
  • International Business Machines Corporation
  • Jubilant Biosys Ltd.
  • Oracle Corporation
  • PerkinElmer Inc.
  • Schrodinger, Inc.
  • Selvita SA
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-521BAA36EBB5

The Drug Discovery Informatics Market was valued at USD 2.90 billion in 2023, expected to reach USD 3.19 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 5.64 billion by 2030.

Drug Discovery Informatics involves applying computational, statistical, and informational techniques to improve the drug discovery process. The necessity arises from the increasing demand for cost-efficient and accelerated drug development processes, as well as the vast complexity involved in targeting biologically active compounds. Its applications span drug target identification, lead discovery, assay development, and virtual screening. In terms of end-use scope, it finds a place in pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.90 billion
Estimated Year [2024] USD 3.19 billion
Forecast Year [2030] USD 5.64 billion
CAGR (%) 9.92%

Market growth is significantly influenced by advancements in big data analytics, AI, and machine learning, which enhance predictive accuracy in drug discovery processes. The surge in personalized medicine and rising adoption of cloud-based solutions contribute further to this growth. Opportunities lie in the integration of AI with informatics for precision medicine, collaborative projects to share molecular data, and expanding into emerging markets. Despite these opportunities, challenges include high costs of informatics tools and data management complexities. Rigorous regulations and data privacy concerns also pose hurdles to market expansion.

Innovation can thrive in areas such as developing intuitive user interfaces for data visualization, streamlining data integration across platforms, and enhancing algorithm robustness for better predictive models. Companies should focus on creating scalable solutions that can continuously adapt to the increasing data volume generated in drug discovery. Collaborating with academic institutes and industry players can also facilitate innovation through shared knowledge and resources.

The market is dynamic and competitive, with numerous players contributing to its rapid evolution. Businesses should prioritize staying at the cutting edge of technology trends, fostering interdisciplinary research, and tailoring informatics solutions to specific therapeutic areas to gain a competitive edge. Through a combination of strategic investments and innovative collaborations, companies can effectively navigate the complexities of drug discovery informatics to foster expansion and market success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Informatics Market

The Drug Discovery Informatics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for precision medicine in rare and orphan disease management
    • Favorable government support for drug discovery procedures
    • Rising use of bioinformatic software for drug discovery and development
  • Market Restraints
    • Involvement of huge cost for development of bio-informatic infrastructure
  • Market Opportunities
    • Potential research investments for the development of drug discovery informatics
    • Integration of next-generation technologies in drug discovery procedures
  • Market Challenges
    • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Informatics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Informatics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Informatics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Informatics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Informatics Market

A detailed market share analysis in the Drug Discovery Informatics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Informatics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Informatics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Informatics Market

A strategic analysis of the Drug Discovery Informatics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Informatics Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Agilent Technologies, Inc., Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Cadence Design Systems, Inc., Certara, Inc., Charles River Laboratories International, Inc., ChemAxon Ltd., Cognizant Technology Solutions Corporation, Collaborative Drug Discovery, Inc, Crown Bioscience, Inc., Dassault Systemes SE, Eurofins DiscoverX Products LLC, Evotec AG, Illumina, Inc., Infosys Limited, InSilico Medicine, International Business Machines Corporation, Jubilant Biosys Ltd., Oracle Corporation, PerkinElmer Inc., Schrodinger, Inc., Selvita S.A., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Solutions, market is studied across Services and Software.
  • Based on Functions, market is studied across Docking, Libraries & Database Preparation, Molecular Modeling, and Sequencing & Target Data Analysis.
  • Based on End-User, market is studied across Contract Research Organizations (CRO) and Pharmaceutical & Biotechnology Companies.
  • Based on Application, market is studied across Drug Development and Drug Discovery. The Drug Development is further studied across Clinical Trials and Preclinical Testing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for precision medicine in rare and orphan disease management
      • 5.1.1.2. Favorable government support for drug discovery procedures
      • 5.1.1.3. Rising use of bioinformatic software for drug discovery and development
    • 5.1.2. Restraints
      • 5.1.2.1. Involvement of huge cost for development of bio-informatic infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential research investments for the development of drug discovery informatics
      • 5.1.3.2. Integration of next-generation technologies in drug discovery procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled and experienced professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Discovery Informatics Market, by Solutions

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. Drug Discovery Informatics Market, by Functions

  • 7.1. Introduction
  • 7.2. Docking
  • 7.3. Libraries & Database Preparation
  • 7.4. Molecular Modeling
  • 7.5. Sequencing & Target Data Analysis

8. Drug Discovery Informatics Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Research Organizations (CRO)
  • 8.3. Pharmaceutical & Biotechnology Companies

9. Drug Discovery Informatics Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Development
    • 9.2.1. Clinical Trials
    • 9.2.2. Preclinical Testing
  • 9.3. Drug Discovery

10. Americas Drug Discovery Informatics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Discovery Informatics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Informatics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accenture PLC
  • 2. Agilent Technologies, Inc.
  • 3. Aragen Life Sciences Ltd.
  • 4. Boehringer Ingelheim International GmbH
  • 5. Cadence Design Systems, Inc.
  • 6. Certara, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. ChemAxon Ltd.
  • 9. Cognizant Technology Solutions Corporation
  • 10. Collaborative Drug Discovery, Inc
  • 11. Crown Bioscience, Inc.
  • 12. Dassault Systemes SE
  • 13. Eurofins DiscoverX Products LLC
  • 14. Evotec AG
  • 15. Illumina, Inc.
  • 16. Infosys Limited
  • 17. InSilico Medicine
  • 18. International Business Machines Corporation
  • 19. Jubilant Biosys Ltd.
  • 20. Oracle Corporation
  • 21. PerkinElmer Inc.
  • 22. Schrodinger, Inc.
  • 23. Selvita S.A.
  • 24. Thermo Fisher Scientific Inc.
  • 25. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY INFORMATICS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY INFORMATICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY INFORMATICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY INFORMATICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DOCKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY LIBRARIES & DATABASE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CRO), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY FUNCTIONS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DRUG DISCOVERY INFORMATICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 233. DRUG DISCOVERY INFORMATICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. DRUG DISCOVERY INFORMATICS MARKET, FPNV POSITIONING MATRIX, 2023